Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MASH”

104 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 104 results

Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Large-scale testing (Phase 3)Active Not RecruitingNCT06161571
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
NASH/MASHNAFLD/MASLD
Akero Therapeutics, Inc 700
Not applicableNot Yet RecruitingNCT07530419
What this trial is testing

Samsung S-Viscosity vs Canon Dispersion Slope in Steatotic Liver Disease (SAVID-SLD)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseFatty LiverLiver Fibrosis
Seoul National University Hospital 95
Not applicableStudy completedNCT05765890
What this trial is testing

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey

Who this might be right for
Non-alcoholic Steatohepatitis (MASH)Non-alcoholic Fatty Liver Disease (MASLD)
Novo Nordisk A/S 675
Not applicableLooking for participantsNCT07330830
What this trial is testing

Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Centre Hospitalier Universitaire de la Guadeloupe 600
Not applicableActive Not RecruitingNCT07185334
What this trial is testing

Single-Stage Prepectoral Placement of Textured Implants Using a Polyester Mesh Endoprostheses With Fluoropolymer Coating in Patients With Breast Cancer

Who this might be right for
Breast CancerBreast ReconstructionCoated Materials+2 more
Saint Petersburg State University, Russia 100
Not applicableStudy completedNCT04009837
What this trial is testing

Manual Therapy and Strengthening for the Hip in Older Adults With Chronic Low Back Pain

Who this might be right for
Chronic Low-back PainHip ImpairmentsHip-spine Syndrome+1 more
University of Delaware 184
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Very early researchLooking for participantsNCT06562361
What this trial is testing

A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.

Who this might be right for
MASHPSCFibrostenotic Crohn's Disease+1 more
Antaros Medical 30
Not applicableNot Yet RecruitingNCT07417683
What this trial is testing

Multicentric Approval Study Trans-Duodenal Barrier for Typ 2 Diabetes With Obesity

Who this might be right for
Typ 2 DiabetesObesityObesity Type 2 Diabetes Mellitus+1 more
Trans-Duodenal Concepts GmbH 126
Not applicableLooking for participantsNCT07188220
What this trial is testing

Patients' Perspectives on Metabolic Dysfunction-associated Steatohepatitis: a Qualitative Study

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis (MASH)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 25
Not applicableStudy completedNCT05630521
What this trial is testing

Testing Feasibility of Medication Adherence Problem Solving for Hypertension

Who this might be right for
HypertensionAdherence, Medication
Rush University Medical Center 40
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07016633
What this trial is testing

To Evaluate the Tolerability, Pharmacokinetics, and Pharmacodynamics of IMM-H014 in Patients With MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Changchun Intellicrown Pharmaceutical Co. LTD 40
Not applicableStudy completedNCT06647095
What this trial is testing

New Non-invasive Biomarkers of Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)

Who this might be right for
HealthySimple Steatosis (SS)Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)+1 more
General University Hospital, Prague 172
Not applicableLooking for participantsNCT05651724
What this trial is testing

Global Research Initiative for Patients Screening on MASH

Who this might be right for
MASHMASLDMASH With Fibrosis+6 more
Julius Clinical 10,000
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Large-scale testing (Phase 3)WithdrawnNCT06594523
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis

Who this might be right for
MASHNASHMetabolic Dysfunction-associated Steatohepatitis+3 more
Sagimet Biosciences Inc.
Not applicableLooking for participantsNCT06813508
What this trial is testing

Prognostic Factors for HCC and Liver Transplantation in Patients With MASLD/MASH

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseHepatocellular CarcinomaMetabolic Dysfunction-Associated Steatohepatitis+1 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 1,000
Not applicableLooking for participantsNCT07013916
What this trial is testing

Fructose is a Metabolic and Inflammatory Pathogenic Factor in Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
MASH - Metabolic Dysfunction-Associated SteatohepatitisMASH With FibrosisSteatosis of Liver
Queen Mary University of London 72
Testing effectiveness (Phase 2)Study completedNCT06675929
What this trial is testing

Test How Well BI 770371 is Tolerated by People With Cirrhosis Caused by a Liver Disease Called MASH

Who this might be right for
Compensated Liver CirrhosisMetabolic Dysfunction Associated Steatohepatitis (MASH)
Boehringer Ingelheim 28
Load More Results